Abbreviations ACE inhibitor: Angiotensin-converting enzyme inhibitor AChEI: Acetylcholinesterase inhibitor Alpha-2AR antagonist: Alpha-2 adrenergic receptor antagonist ARB: Angiotensin receptor blocker ASS: Acetylic salicylic acid ATC: Anatomical therapeutic chemical classification system (drug classification system, WHO) BAN: British approved name CLL: Chronic lymphocytic leukemia COX inhibitor: Cyclooxygenase inhibitor DDD: Defined daily dose DGIM: German Society for Internal Medicine EGFR inhibitor: Epidermal growth factor receptor inhibitor GORD: Gastro-oesophageal reflux disease HER2 inhibitor: Human epidermal growth factor 2 inhibitor IMPP: Institut fr medizinische und pharmazeutische Prfungsfragen (Institute for Medical and Pharmaceutical Examination Questions, Germany) INN: International nonproprietary name IUPHAR: International union of basic and clinical pharmacology JAK inhibitor: Janus kinase inhibitor MOR agonist: -Opioid receptor agonist mTOR inhibitor: Mammalian target of rapamycin kinase inhibitor MxR agonist: Muscarinic receptor agonist NaSSA: Noradrenergic and specific serotonergic enhancer NbN: Neuroscience-based nomenclature NCC: Na + /Cl- cotransporter NE/5-HT enhancer: Norepinephrine and serotonin enhancer NKCC: Na + /K + /2Cl- cotransporter NKLM: Nationaler kompetenzbasierter Lernzielkatalog Medizin (National competence-based learning objectives catalogue for medicine, Germany) NMDA antagonist: N-methyl-D-aspartate antagonist NSAID: Non-steroidal anti-inflammatory drug (COX inhibitor) PAH: Pulmonary arterial hypertension PPI: Proton pump inhibitor SLGT-1/2 inhibitor: Sodium-glucose cotransporter 1/2 inhibitor SSRI: Selective serotonin reuptake inhibitors TYK2 inhibitor: Tyrosine kinase 2 inhibitor USAN: United States approved name WHO: World Health Organization References Abd-Elsayed A, Ferguson K, Papapetrou P (2024) 'Benzodiazepines', in Alaa Abd-Elsayed (ed.), Basic Anesthesia Review (New York, 2024
Here is exactly how the cross-sell works, what questions to ask, and how much it adds to lifetime value per patient
While side effects are common with this class of medications, most are mild-to-moderate and transient
Stewart, M
Even with a well-structured diet and oral supplementation, certain nutrients may not reach adequate levels in patients with absorption limitations, increased physiological demand, or documented deficiency
& Lipska, K
